Skip to main content
Premium Trial:

Request an Annual Quote

Astute Medical Raises $6.2M in Series A Round

NEW YORK (GenomeWeb News) – Astute Medical said today that it has raised $6.2 million in a Series A round of financing led by De Novo Ventures.
 
San Diego-based Astute is developing protein biomarker-based tests for the rapid diagnosis and risk assessment of patients with hospital-acquired infections. The firm said it would use the funds from the first round of financing for research and development of the biomarkers.
 
Astute was founded last year and is led by CEO Christopher Hibberd, a former SVP of corporate development at Biosite, and CSO Paul McPherson, a former VP of research and development at Biosite, which was acquired last year for $1.7 billion by Inverness Medical Innovations.